NCT05474547 (Med-YMH) is a NA clinical trial of Meditation in Healthy, sponsored by Habib University.

Who is sponsoring NCT05474547?

NCT05474547 is sponsored by Habib University.

What drugs are being tested in NCT05474547?

Interventions in NCT05474547: Meditation.

Is NCT05474547 still recruiting?

NCT05474547 is currently status unknown. Last updated 28 February 2023.

Last reviewed 2023-02-28 · How we verify

NCT05474547: Med-YMH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Meditation and Youth Mental Health

Status unknown NA Last updated 28 February 2023

What this trial tests

NA trial testing Meditation in Healthy in 14 participants. Status unknown.

Timeline

25 July 2023

Primary endpoint
30 September 2023

25 December 2023

Quick facts

Lead sponsor	Habib University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	14
Start date	25 July 2023
Primary completion	30 September 2023
Estimated completion	25 December 2023

Drugs / interventions tested

Meditation

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Habib University

Who can join

Adults 16 to 27, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Youth is a crucial time of life when physical and mental well-being is critical. Students are vulnerable due to academic and pandemic stresses. Meditation research has been showing effects on improved parameters of mental health (sleep quality, attention, memory, and concentration), emotional wellbeing (reduced stress and anxiety), and physiological parameters (better metabolism, circulation, immunity, etc.), which influence the life and academic performance of students. This study is designed to examine the feasibility of conducting a meditation intervention among students of a small liberal arts university in Pakistan. Future larger and longer randomized controlled clinical trials on high-risk youth may be planned at a later stage to see the impact on academic performance and career progression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Meditation

Trials testing the same drug.

NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
NCT07310992 — Effect of Meditation as an Adjunct to Cardiac Rehabilitation · NA · not yet recruiting
NCT07176013 — Immersive Virtual Reality Meditation in Voice Therapy · NA · enrolling by invitation
NCT06866288 — Belongingness in Nursing Through Mindfulness - BEING Mindful: A Pilot Study · NA · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05474547 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Habib University
Last refreshed: 28 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05474547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing